# Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens

> **NCT03298945** · PHASE4 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 2239 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Miralax-Gatorade Prep
- **DRUG:** Golytely

## Key facts

- **NCT ID:** NCT03298945
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-13
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 2239 (ACTUAL)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03298945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03298945, "Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03298945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*